Cargando…
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608826/ https://www.ncbi.nlm.nih.gov/pubmed/34811350 http://dx.doi.org/10.1038/s41421-021-00347-1 |
| _version_ | 1784602812623093760 |
|---|---|
| author | Cheng, Lin Song, Shuo Fan, Qing Shen, Senlin Wang, Haiyan Zhou, Bing Ge, Xiangyang Ju, Bin Zhang, Zheng |
| author_facet | Cheng, Lin Song, Shuo Fan, Qing Shen, Senlin Wang, Haiyan Zhou, Bing Ge, Xiangyang Ju, Bin Zhang, Zheng |
| author_sort | Cheng, Lin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8608826 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86088262021-12-03 Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies Cheng, Lin Song, Shuo Fan, Qing Shen, Senlin Wang, Haiyan Zhou, Bing Ge, Xiangyang Ju, Bin Zhang, Zheng Cell Discov Correspondence Springer Singapore 2021-11-23 /pmc/articles/PMC8608826/ /pubmed/34811350 http://dx.doi.org/10.1038/s41421-021-00347-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Cheng, Lin Song, Shuo Fan, Qing Shen, Senlin Wang, Haiyan Zhou, Bing Ge, Xiangyang Ju, Bin Zhang, Zheng Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title | Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title_full | Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title_fullStr | Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title_full_unstemmed | Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title_short | Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| title_sort | cross-neutralization of sars-cov-2 kappa and delta variants by inactivated vaccine-elicited serum and monoclonal antibodies |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608826/ https://www.ncbi.nlm.nih.gov/pubmed/34811350 http://dx.doi.org/10.1038/s41421-021-00347-1 |
| work_keys_str_mv | AT chenglin crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT songshuo crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT fanqing crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT shensenlin crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT wanghaiyan crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT zhoubing crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT gexiangyang crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT jubin crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies AT zhangzheng crossneutralizationofsarscov2kappaanddeltavariantsbyinactivatedvaccineelicitedserumandmonoclonalantibodies |